Financial report interval: 2025.12.31 - 2026.03.31
Preview: Novavax(NVAX) predict that the Revenue is 139.51 M (-79.07%), Beat estimate;the EBIT is -15.43 M (-103%), Beat estimate;the EPS is -0.06 (-102.1%), Beat estimate.